What happened
OPTIMAL-DIABETES evaluates intensive blood pressure control for major cardiovascular event prevention in type 2 diabetes.
Why the trial, key points, tables, limitations, PICO, abstract, media & sources
Expert reaction
AHA Scientific Sessions 2026
0 experts have reacted so far. We show the split once 3 have.
Expert labels are toward OPTIMAL-DIABETES's result, from named public quotes (n=0). As of Oct 22, 2026.
Intensive blood pressure control for the prevention of major cardiovascular events in patients with type 2 diabetes: the OPTIMAL-DIABETES trial
Intensive blood pressure control for the prevention of major cardiovascular events in patients with type 2 diabetes: the OPTIMAL-DIABETES trial. Session: LBS.03. Late-breaking trial at AHA Scientific Sessions 2026. Results pending.
No takes yet. Share an insight, caveat, or question.
Andrade et al. (2026) studied this question. Intensive blood pressure control is being evaluated for the prevention of major cardiovascular events in patients with type 2 diabetes in the OPTIMAL-DIABETES trial, with results currently pending.